Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,599 | -5,141 | -4,411 | -1,917 | -22,999 |
| Depreciation Amortization | 4,200 | 2,919 | 1,952 | 953 | 3,952 |
| Accounts receivable | -6,161 | -10,445 | -6,458 | -3,447 | -452 |
| Accounts payable and accrued liabilities | -141 | 2,505 | 1,746 | 1,726 | -1,568 |
| Other Working Capital | -5,880 | -10,726 | -5,866 | -2,066 | -651 |
| Other Operating Activity | 17,349 | 15,866 | 9,571 | 3,740 | 8,197 |
| Operating Cash Flow | $-3,232 | $-5,022 | $-3,466 | $-1,011 | $-13,521 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,733 | -1,633 | -1,407 | -749 | -1,874 |
| Net Acquisitions | -40,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-42,733 | $-1,633 | $-1,407 | $-749 | $-1,874 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -25,208 | -25,129 | -25,052 | -12,575 | -292 |
| Common Stock Issued | 153,472 | 150,261 | 145,253 | 4,737 | 59,418 |
| Other Financing Activity | -977 | -810 | -676 | -556 | 373 |
| Financing Cash Flow | $127,287 | $124,322 | $119,525 | $-8,394 | $59,499 |
| Beginning Cash Position | 78,598 | 78,598 | 78,598 | 78,598 | 34,494 |
| End Cash Position | 159,920 | 196,265 | 193,250 | 68,444 | 78,598 |
| Net Cash Flow | $81,322 | $117,667 | $114,652 | $-10,154 | $44,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,232 | -5,022 | -3,466 | -1,011 | -13,521 |
| Capital Expenditure | -2,756 | -1,656 | -1,424 | -765 | -1,874 |
| Free Cash Flow | -5,988 | -6,678 | -4,890 | -1,776 | -15,395 |